ProNerve announced the acquisition of Broncor, one of the largest providers of intraoperative neuromonitoring (IONM) services in the midwestern United States. Headquartered in St. Louis, Broncor serves several hospital clients across 3 states. Broncor represents ProNerve’s forth acquisition in the past several months and further positions the Company as a national provider of IONM services and the market leading provider in the United States. “This transaction furthers our mission of being the leading provider of high quality Intraoperative Neuromonitoring by giving ProNerve an extremely strong position in the marketplace and adds the strengths of Broncor to our own.” said Luke Johnson, Chief Executive Officer of ProNerve.
Brian Larson, of Broncor said of the transaction, “Over the last decade, Broncor has grown into an incredible team focused on patient care, employee satisfaction and customer service. We are very fortunate to have found a partner in ProNerve whose values and corporate culture so closely align with ours. The advantages and resources ProNerve can provide our patients, staff, and clients will insure that our standard of quality care and human concern will flourish and grow for years to come.”
About ProNerve, LLC:
ProNerve is one of the leading providers of intraoperative neuromonitoring services in the United States. IONM involves the use of a variety of electro-physiological monitoring procedures during surgery to allow for early warning and avoidance of injury to nervous systems structures. ProNerve’s IONM services include onsite technical support provided by trained technologists in the operating room, combined with real-time professional oversight delivered remotely by the Company’s team of clinicians. ProNerve’s customers include health systems, acute care hospitals, specialty hospitals, ambulatory surgery centers, surgeons and physician groups.